7月21日 - ** Dyne Therapeutics（DYN.O）股价在盘后交易中下跌14%，至20.50美元，该公司正计划进行股权融资
** 专注于神经肌肉疾病领域的DYN公司 (link) 启动3亿美元股票发行
** 摩根士丹利、杰富瑞和Evercore担任联合簿记管理人，LifeSci Capital和雷蒙德·詹姆斯参与承销
** DYN股价周二收盘上涨1.6%，报23.83美元，年初至今累计上涨22%
** 这家总部位于马萨诸塞州沃尔瑟姆的公司 流通股约为 1.653亿股，市值近40亿美元
** 据LSEG数据显示，16位分析师中有15位给予该股“强烈买入”或“买入”评级，1位给予“持有”评级；目标价中位数为40美元
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.